Luisa Caparoula
Family Medicine · Chester, VANPI 1962845016
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 93 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 22.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $730 and has fallen 97.6% since, to $18 in 2023.
Across 93 payments — averaging $15.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$311
- Novo Nordisk$208
- Merck$125
- Lilly USA, LLC$88
- Astellas Pharma US Inc$78
- Boehringer Ingelheim$76
- plus $527 from 19 others
What the payments were for
- Food & beverage$1,414100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 15 | $311 |
| Novo Nordisk | 15 | $208 |
| Merck | 12 | $125 |
| Lilly USA, LLC | 7 | $88 |
| Astellas Pharma US Inc | 4 | $78 |
| Boehringer Ingelheim | 5 | $76 |
| Pfizer | 5 | $63 |
| AbbVie | 4 | $62 |
| Amgen | 4 | $60 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $53 |
| GSK | 3 | $39 |
| Bayer | 2 | $28 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $28 |
| Johnson & Johnson | 2 | $25 |
| Biohaven Pharmaceuticals, Inc. | 1 | $23 |
| Dexcom, Inc. | 1 | $18 |
| Abbott | 1 | $17 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $15 |
| Ultragenyx Pharmaceutical Inc. | 1 | $15 |
| Amarin Pharma, Inc. | 1 | $15 |
| Esperion Therapeutics, Inc. | 1 | $14 |
| Currax Pharmaceuticals LLC | 1 | $13 |
| Shire North American Group Inc | 1 | $13 |
| Sanofi Pasteur Inc. | 1 | $13 |
| Kowa Pharmaceuticals America, Inc. | 1 | $12 |
How this compares
$1,414 in reported general payments places this provider in the 70th percentile of 2,553 family medicine providers in Virginia.
Other family medicine in Chester
- Oluwaronke AwosikaFort Gregg Adams$397K
- Monique MatuskowitzNorfolk$110K
- Paul StairsRichmond$105K
- Edwin RobinsonRichmond$83K
- Benjamin PhilpottRocky Mount$64K
- John MolaiyArlington$64K
- Catherine VarneyZion Crossroads$47K
- Jordan TranWinchester$42K
- John ClayColonial Heights$40K
- Thomas RobesonNewport News$34K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.